Table 3.
Worldwide distribution of the most common KIR genotypes (Human Genome Diversity Project)A and comparison with the Turkish population
| Human Genome Project DataA | Turkey | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Centromeric/telomeric genotype | Worldwide | Africa | Mideast | Europe | CSAsia | EAsia | Oceania | America | |
| cAA/tAA | 31.40% | 32.70% | 37.00% | 28.40% | 27.80% | 46.00% | 0.00% | 24.00% | 23.54% |
| cAA/tAB | 11.00% | 1.80% | 10.10% | 10.10% | 11.10% | 16.00% | 5.40% | 18.00% | 11.89% |
| cAB2/tAA | 8.50% | 8.80% | 18.50% | 12.20% | 3.90% | 8.40% | 0.00% | 6.00% | 13.11% |
| cAB1/tAA | 7.20% | 8.00% | 21.00% | 5.40% | 11.70% | 2.50% | 2.70% | 0.00% | 10.44% |
| cAB1/tAB | 6.40% | 2.70% | 9.20% | 17.60% | 8.30% | 1.30% | 5.40% | 2.00% | 17.23% |
| cAB2/tAB | 5.0% | 0.0% | 3.40% | 6.80% | 2.80% | 3.40% | 2.70% | 21.00% | 7.28% |
| tAAB | 47.10% | 49.50% | 76.50% | 46.00% | 43.40% | 56.90% | 2.70% | 30.00% | 50.97% |
| tAA w ligands | 17.73% | ||||||||
| tABB | 22.40% | 4.50% | 22.70% | 34.50% | 22.20% | 20.70% | 13.50% | 41.00% | 40.53% |
| tAB1C | 29.13% | ||||||||
| tAB1 w ligandsC | 17.48% | ||||||||
| tBB | 5.83% | ||||||||
| tBB w ligands | 4.81% | ||||||||
| cAB1B | 13.60% | 10.70% | 30.20% | 23.00% | 20.00% | 3.80% | 8.10% | 2.00% | 32.28% |
| cAB1 w ligands | 24.04% | ||||||||
AAdapted from Hollenbach et al. (2012)
BEstimates calculated from worldwide distribution
CIn this current study, we have applied an updated version of the telomeric genotype combination (20)